In patients with Chediak-Higashi syndrome undergoing allogeneic SCT, does adding etoposide to the conditioning regimen improve the outcome?

Bone Marrow Transplant. 2007 Sep;40(6):603. doi: 10.1038/sj.bmt.1705774. Epub 2007 Jul 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Chediak-Higashi Syndrome / therapy*
  • Etoposide / therapeutic use*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Transplantation Conditioning / methods*
  • Transplantation, Homologous

Substances

  • Antineoplastic Agents, Phytogenic
  • Etoposide